Silizom 5gm Injection

Product Overview

About Silizom 5gm Injection

Silizom 5gm Injection is a prescription medicine utilized in clinical settings for the management of liver-related conditions. Formulated as an intravenous injection, this product provides targeted delivery of its active pharmaceutical ingredient to support metabolic functions in patients experiencing hepatic impairment. It is manufactured under strict pharmaceutical quality standards to ensure safety, efficacy, and sterility for hospital and clinical administration.

Key Benefits & Uses

• Helps manage hyperammonemia associated with acute and chronic liver diseases such as cirrhosis.
• Supports the reduction of elevated blood ammonia levels by enhancing urea synthesis in the liver.
• Assists in the improvement of neuropsychiatric symptoms related to hepatic encephalopathy under medical supervision.

Active Ingredient & Action

The primary active pharmaceutical ingredient in this medicine is L-Ornithine L-Aspartate at a strength of 5gm per unit. L-Ornithine L-Aspartate is a stable salt of two natural amino acids, ornithine and aspartic acid. It works by stimulating two critical pathways for ammonia detoxification, namely the urea cycle and glutamine synthesis, thereby helping to lower toxic ammonia concentrations in the bloodstream.

Important Notes

Silizom 5gm Injection must be administered strictly by qualified healthcare professionals in a clinical environment. Patients should inform their doctor of any pre-existing medical conditions, allergies, or concurrent medications prior to administration. Dosage and duration of treatment are determined exclusively by the attending physician based on the specific condition and clinical response of the patient.